Policy of Making Research and Development the Top Priority
First written in FY2019. 8 of 15 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 3 of 34 companies on the "Worse" side.
7 other companies' latest entry also says "Other".
- FY2026Higher R&D expenses and a slight decline in headcountAnnual report
「The Group regards R&D as its highest priority in business development. R&D is conducted by 88 R&D staff, including 24 employees with doctoral degrees, out of a total workforce of 625 (as of 31 July 2026).」
While continuing to treat R&D as its highest priority, the number of R&D staff declined from 90 in the previous fiscal year to 88. R&D expenses increased to ¥1,858 million. - 2026-06-10RestatedEarnings
「To create this new value, we are focusing on R&D investment, new product development and the development of sales channels.」
The company continues to pursue business initiatives including R&D investment. - FY2024AdvancedAnnual report
「The Group regards R&D as its top priority in developing its business and conducts R&D with 90 staff, including 25 PhDs, out of a total workforce of 642 (as of 31 July 2024).」
The company has maintained its policy of making R&D a top priority and expanded its R&D staff to 90. - FY2024-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company states that there have been no material changes to its policy of making R&D a top priority in developing its business. - FY2023AdvancedAnnual report
「The Group regards R&D as its top priority in developing its business and conducts R&D with 82 staff, including 24 PhDs, out of a total workforce of 670 (as of 31 July 2023).」
The company has maintained its policy of making R&D a top priority and expanded its R&D staff to 82. - FY2023-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company states that there have been no material changes to its policy of making R&D a top priority. - FY2022AdvancedAnnual report
「The Group regards R&D as its top priority in developing its business and conducts R&D with 71 staff, including 19 PhDs, out of a total workforce of 624 (as of 31 July 2022).」
The company has maintained its policy of making R&D a top priority, and the number of R&D staff increased to 71. - FY2022-Q3RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company states that there have been no material changes to its policy of emphasizing R&D or to its R&D activities. - FY2022-Q1AdvancedAnnual report
「To meet these needs and achieve the theme of the medium-term management plan, “Creating New Value,” the Group actively invested in R&D in its functional materials and biomedical businesses, with particular emphasis on strengthening the recruitment of R&D personnel.」
Under its policy of emphasizing R&D, the company invested in R&D in its functional materials and biomedical businesses and strengthened recruitment of R&D personnel. - FY2021AdvancedAnnual report
「The Group regards R&D as its top priority in developing its business and conducts R&D with 47 staff, including 15 PhDs, out of a total workforce of 293 (as of 31 July 2021).」
The company has continued its policy of making R&D a top priority, and the number of R&D staff increased from 38 in the previous disclosure to 47. - FY2021-Q3RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company states that there have been no material changes to its policy of emphasizing R&D or to its R&D activities. - FY2021-Q2RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The company states that there have been no material changes to its policy of emphasizing R&D or to its R&D activities. - FY2020-Q2RestatedAnnual report
「There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company states that there have been no material changes to its policy of emphasizing R&D or to its R&D activities. - FY2020-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company states that there have been no material changes to its policy of emphasizing R&D or to its R&D activities. - FY2019First statedAnnual report
「The Group regards R&D as its top priority in developing its business and conducts R&D with 38 staff, including 18 PhDs, out of a total workforce of 146.」
The company positions R&D as its top priority in developing its business and has assigned 38 R&D staff, including 18 PhDs.